BVF »

Nls Pharmaceutics shares owned by BVF

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSP) shares owned by BVF from 13F filings

Historical chart of BVF investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by BVF

Quarter filed Position value Share count Share price at filing
2025-09-30 $263k 144k 1.83
2025-06-30 $417k 144k 2.90
2025-03-31 $221k 144k 1.54
2024-12-31 $303k 144k 2.11
2024-09-30 $728k 144k 5.07

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cidara Therapeutics Com New (CDTX)
Gh Research Ordinary Shares (GHRS)
Mirum Pharmaceuticals (MIRM)
Xoma Royalty Corporation Com New (XOMA)
Structure Therapeutics Sponsored Ads (GPCR)
Kura Oncology (KURA)
Septerna (SEPN)
Palvella Therapeutics Inc Ne (PVLA)
Nektar Therapeutics Com New (NKTR)
Zymeworks Del (ZYME)
Axsome Therapeutics (AXSM)

View all positions for BVF

Top funds holding Nls Pharmaceutics

BVF
Morgan Stanley
UBS Group

View all funds holding Nls Pharmaceutics